يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Nadezhda A. Shostak"', وقت الاستعلام: 0.45s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المصدر: Modern Rheumatology Journal; Том 7, № 2 (2013); 66-70 ; Современная ревматология; Том 7, № 2 (2013); 66-70 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2013-2

    وصف الملف: application/pdf

    Relation: https://mrj.ima-press.net/mrj/article/view/483/461; World Health Organization. The burden of musculoskeletal conditions at the start of the new millennium. Available at: http://whqlib-doc.who.int/trs/WHO_TRS_919.pdf. Насонов Е.Л., Насонова В.А. Ревматология. Национальное руководство. М.: ГЭОТАР-Медиа, 2010;720 с. Gaujoux-Viala C., Smolen J., Landewe R. et al. Ann Rheum Dis 2010;69:1004-9. Насонова В.А., Насонов Е.Л., Алекперов Р.Т. и др. Рациональная фармакотерапия ревматических заболеваний: руководство для практикующих врачей. М.: Литтерра, 2003;507 с. Emery P., Breedveld F.C., Dougados M. et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61(4):290—7. Stuhlmeier K. Effects of leflunomide on hyaluronan synthases (HAS): NF-kappa B-independent suppression of IL-1-induced HAS1 transcription by leflunomide. J Immunol 2005;174(11):7376—82. Rückemann K., Fairbanks L., Carrey E.A. et al. Leflunomide Inhibits Pyrimidine de Novo Synthesis in Mitogen-stimulated T-lymphocytes from Healthy Humans. J Biol Chem 1998;273(34):21682—91. Silva H., Cao W., Shorthouse R. et al. In vitro and in vivo effects of leflunomide, Brequinar, and cyclosporine on pyrimidine biosynthesis. Transplant Proc 1997;29(1-2):1292-3. Scott D.L., Schattenkirchner M., Smolen J.S. et al. Efficacy of leflunomide vs placebo vs sulfasalazine in rheumatoid arthritis: effect of disease duration. Arthr Rheum 1998;41:155. Grisar J., Aringer M., Köller M. et al. Leflunomide inhibits transendothelial migration of peripheral blood mononuclear cells Ann Rheum Dis 2004;63:1632-7. Li E., Tam L., Tomlinson B. Leflunomide in the treatment of rheumatoid arthritis. Clin Ther 2004;26(4):447-59. Dougados M., Emery P., Lemmel E. et al. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? Ann Rheum Dis 2005;64:44-51. Cohen S., Cannon G.W., Schiff M. et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthr Rheum 2001;44(9):1984—92.; https://mrj.ima-press.net/mrj/article/view/483

  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المصدر: Modern Rheumatology Journal; Том 6, № 1 (2012); 15-21 ; Современная ревматология; Том 6, № 1 (2012); 15-21 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2012-1

    وصف الملف: application/pdf

    Relation: https://mrj.ima-press.net/mrj/article/view/394/372; Ревматология. Клинические рекомендации. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа, 2008; 288 с. Osteoarthritic Disorders. Kuettner K.E., Goldberg V.M. (ed.). Rosemont, IL: American Academy of Orthopedic Surgeons, 1995. Seedhom B.B. Conditioning of cartilage during normal activities is an important factor in the development of osteoarthritis. Rheumatology 2006; 45(2): 146—9. Beck M., Leunig M., Clarke E. et al. Hip morphology influences the pattern of damage to the acetabular cartilage: femoroacetabular impingement as a cause of early osteoarthritis of the hip. J Bone Joint Surg Br 2005; 87: 1012—18. Ganz R., Leunig M., Leunig-Ganz K. et al. The etiology of osteoarthritis of the hip. An Integrated Mechanical Concept. Clin Orthop Relat Res 2008; 466(2): 264—72. Goldriring M.B. The role of the chondrocyte in osteoarthritis. Arthr Rheum 2000; 43(9): 1916—26. Mastbergen S.C., Bijlsma J.W., Lafeber F.P. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2. Ann Rheum Dis 2008; 67(1): 52—8. Цветкова Е.С. Современная терапия остеоартроза — патогенетическое обоснование. Тер. арх. 2004; 5: 77—9. Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии. РМЖ 2004; 12: 1133—6. Henrotin Y.E. Bone-derived mediators and cartilage degradation. Ann Rheum Dis 2006; 65: 10. Westacott C.I., Webb G.R., Elson C.J. Cells from osteoarthritic bone produse enzymes which degrade cartilage. Trans Orthop Res Soc 1998; 23: 919. Li B., Marshall D., Roe M. et al. The electron microscope appearance of the subchondral bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999; 195: 101—10. Sowers M.R., Zobel D., Weissfeld L. et al. Progression of osteoarthritis of the hand and metacarpal bone loss. A twenty-year follow up of incident cases. Arthr Rheum 1991; 34: 36—42. Altman R., Alarcon G., Appelrouth D. et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rheum 1991; 34: 505—14. Watts R., Climil G., Hall F. Oxford Desk Reference: Rheumatology. Oxford: University Press, 2009,603. Arthritis and Allied Conditioins: A Textbook of Rheumatology, 13th ed. W.J. Koopman (ed.). Williams & Wilkins, 1997; 2374. Klippel J.H. Primer on the Rheumatic Diseases,12th ed. In: L.J. Grofford, J.H. Stone, C.M. Weyand. Atlanta, Georgia, 2001. Рекомендации Международного научно-исследовательского общества по проблемам остеоартрита.; https://mrj.ima-press.net/mrj/article/view/394

  7. 7
    Academic Journal
  8. 8
  9. 9